Ionis Pharmaceuticals (IONS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2000 | 12-1999 | 12-1998 | 12-1997 | 12-1996 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -53,485 | -59,225 | -42,980 | -31,066 | -26,521 |
| Depreciation Amortization | 5,535 | 5,196 | 4,250 | 3,178 | 2,633 |
| Accounts receivable | 2,083 | -1,963 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | -917 | 171 | N/A | N/A | N/A |
| Other Working Capital | -908 | -9,515 | -7,340 | 6,875 | 2,727 |
| Other Operating Activity | 24,506 | 17,248 | 11,350 | 459 | 9 |
| Operating Cash Flow | $-23,186 | $-48,088 | $-34,720 | $-20,554 | $-21,152 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -69,949 | 13,492 | N/A | N/A | N/A |
| PPE Investments | -1,649 | -4,791 | -4,430 | -3,454 | -862 |
| Purchase Of Investment | -20,599 | -14,233 | N/A | N/A | N/A |
| Purchase Sale Intangibles | -3,182 | -2,642 | N/A | N/A | N/A |
| Other Investing Activity | -3,182 | -2,642 | 13,530 | -11,708 | -10,409 |
| Investing Cash Flow | $-95,379 | $-8,174 | $9,100 | $-15,162 | $-11,271 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 8,583 | 3,233 | N/A | N/A | N/A |
| Debt Repayment | -3,939 | -3,631 | N/A | N/A | N/A |
| Common Stock Issued | 118,240 | 64,338 | N/A | N/A | N/A |
| Other Financing Activity | 0 | 0 | 15,120 | 36,736 | 23,042 |
| Financing Cash Flow | $122,884 | $63,940 | $15,120 | $36,736 | $23,042 |
| Beginning Cash Position | 35,296 | 27,618 | 38,100 | 37,082 | 46,463 |
| End Cash Position | 39,615 | 35,296 | 27,610 | 38,102 | 37,082 |
| Net Cash Flow | $4,319 | $7,678 | $-10,480 | $1,020 | $-9,381 |
| Free Cash Flow | |||||
| Operating Cash Flow | -23,186 | -48,088 | -34,720 | -20,554 | -21,152 |
| Capital Expenditure | -1,649 | -4,791 | N/A | N/A | N/A |
| Free Cash Flow | -24,835 | -52,879 | -34,720 | -20,554 | -21,152 |